Franklin Resources’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.22M Buy
106,949
+41,129
+62% +$2.49M ﹤0.01% 1421
2026
Q1
$3.65M Buy
+65,820
New +$3.54M ﹤0.01% 1669
2025
Q4
Sell
-47,332
Closed -$11.6M 3124
2025
Q3
$11.6M Sell
47,332
-307,176
-87% -$7.05M ﹤0.01% 1118
2025
Q2
$7.87M Buy
354,508
+117
+0% +$2.45K ﹤0.01% 1210
2025
Q1
$6.59M Buy
354,391
+21
+0% +$350 ﹤0.01% 1244
2024
Q4
$4.69M Hold
354,370
﹤0.01% 1374
2024
Q3
$12.3M Sell
354,370
-111,003
-24% -$3.79M ﹤0.01% 1047
2024
Q2
$11.7M Hold
465,373
﹤0.01% 1025
2024
Q1
$10.5M Buy
465,373
+60,258
+15% +$1.43M ﹤0.01% 1066
2023
Q4
$8.68M Buy
405,115
+75,025
+23% +$1.29M ﹤0.01% 968
2023
Q3
$5.93M Buy
+330,090
New +$6.3M ﹤0.01% 1040
2022
Q4
Sell
-10,222
Closed -$261K 2329
2022
Q3
$261K Buy
10,222
+177
+2% +$4.15K ﹤0.01% 1903
2022
Q2
$204K Sell
10,045
-4,787
-32% -$106K ﹤0.01% 2015
2022
Q1
$367K Buy
14,832
+8
+0.1% +$242 ﹤0.01% 1941
2021
Q4
$515K Sell
14,824
-76
-0.5% -$2.41K ﹤0.01% 1893
2021
Q3
$404K Buy
+14,900
New +$378K ﹤0.01% 1969
2019
Q4
Sell
-275,500
Closed -$9.64M 1526
2019
Q3
$9.64M Hold
275,500
0.01% 889
2019
Q2
$15.5M Hold
275,500
0.01% 801
2019
Q1
$20.1M Hold
275,500
0.01% 746
2018
Q4
$17.6M Hold
275,500
0.01% 743
2018
Q3
$27.5M Buy
+275,500
New +$22.9M 0.01% 690
2018
Q2
Sell
-208,300
Closed -$21.7M 1468
2018
Q1
$21.7M Sell
208,300
-117,300
-36% -$13.2M 0.01% 764
2017
Q4
$32.8M Buy
325,600
+46,400
+17% +$3.42M 0.02% 658
2017
Q3
$9.76M Hold
279,200
﹤0.01% 948
2017
Q2
$6.68M Hold
279,200
﹤0.01% 1038
2017
Q1
$7.75M Buy
+279,200
New +$6.5M ﹤0.01% 1026

Other funds holding ANAB

Franklin Resources's ANAB Position: Q2 2026 in Review

Franklin Resources increased its AnaptysBio (ANAB) stake by 62% in Q2 2026, buying an estimated $2.49M and bringing the position to 106,949 shares worth $7.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1421.

Franklin Resources first reported a position in ANAB in Q1 2017 and has held it in 26 quarters since. The position peaked at $32.8M in Q4 2017. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Franklin Resources held 106,949 shares of AnaptysBio worth $7.22M as of Q2 2026.
  • Franklin Resources bought 41,129 AnaptysBio shares in Q2 2026, an estimated $2.49M.
  • AnaptysBio made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1421 holding.
  • Franklin Resources first reported a position in AnaptysBio in Q1 2017 and has held it in 26 quarters since.
  • Franklin Resources's AnaptysBio position peaked at $32.8M in Q4 2017.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.